![]() |
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
|
Your cart is empty |
||
|
Books > Medicine > Nursing & ancillary services > Pharmacy / dispensing
Drug Design and Development outlines the processes involved in the design and development of new drugs and emphasises the significance of these processes to the practice of pharmacy. The book highlights why it is important that all practicing pharmacists, including those working in hospitals or high street stores, have a solid understanding of the process of the design and development of the drugs they interact with. It adopts an integrated approach, formulated to complement courses which are designed in line with the General Pharmaceutical Council's new curriculum requirements. Furthermore, this is the only integrated textbook to consider both drug design and development within one volume. Throughout the book, the journey of the drug, from discovery to market, is presented in an integrated fashion, emphasising the interconnection of all the processes involved.
I have been privileged to witness and participate in the great growth of knowledge on chemical carcinogenesis and mutagenesis since 1939 when I entered graduate school in biochemistry at the University of Wisconsin Madison. I immediately started to work with the carcinogenic aminoazo dyes un der the direction of Professor CARL BAUMANN. In 1942 I joined a fellow graduate student, ELIZABE1H CAVERT, in marriage and we soon commenced a joyous part nership in research on chemical carcinogenesis at the McArdle Laboratory for Cancer Research in the University of Wisconsin Medical School in Madison. This collaboration lasted 45 years. I am very grateful that this volume is dedi cated to the memory of Elizabeth. The important and varied topics that are reviewed here attest to the continued growth of the fields of chemical car cinogenesis and mutagenesis, including their recent and fruitful union with viral oncology. I feel very optimistic about the application of knowledge in these fields to the eventual solution of numerous problems, including the detection and estimation of the risks to humans of environmental chemical carcinogens and re lated factors."
"Oxalate Metabolism in Relation to Urinary Stone" is the third monograph to appear in the "Bloomsbury Series". Edited by Alan Rose, the book describes the current clinical and biochemical features of oxalate metabolism. Its content and direction fulfil the goals of the Series emphasising the strong links between basic science and clinical medicine. London Jack Tinker 30 March 1988 Preface The first oxalate workshop was held in London in 1979 and the proceedings published privately by the Wellcome Foundation. At that time the importance of urinary oxalate as a risk factor more important for calcium oxalate stone formation than urinary calcium had been recognized. Nevertheless measurements of urinary oxalate still left a lot to be desired and in particular the non-enzymatic conversion of ascorbate to oxalate had not been rediscovered so that many measurements must have been wrong. Plasma oxalate was still difficult or impossible to measure by any reasonable, accessible methods and consequently there was still much argument and speculation about the handling of oxalate by the kidneys. A lot of work has been performed in the last eight years on oxalate metabolism and it therefore seemed to the organisers to be a good time to hold a second oxalate workshop.
Handbook of Analytical Quality by Design addresses the steps involved in analytical method development and validation in an effort to avoid quality crises in later stages. The AQbD approach significantly enhances method performance and robustness which are crucial during inter-laboratory studies and also affect the analytical lifecycle of the developed method. Sections cover sample preparation problems and the usefulness of the QbD concept involving Quality Risk Management (QRM), Design of Experiments (DoE) and Multivariate (MVT) Statistical Approaches to solve by optimizing the developed method, along with validation for different techniques like HPLC, UPLC, UFLC, LC-MS and electrophoresis. This will be an ideal resource for graduate students and professionals working in the pharmaceutical industry, analytical chemistry, regulatory agencies, and those in related academic fields.
Unique analysis of drugs and poisons to facilitate testing in all laboratories even by inexperienced chemists Includes source of chemicals needed for the experiments Texts are composed by 67 experts in analyzing the respective compounds Clear and uniform structure of chapters for ease of reading The text is illustrated by many diagrams and tables
Are your exams coming up? Are you drowning in textbooks and lecture notes and wondering where to begin? Take the FASTtrack route to successful study for your examinations. FASTtrack is a new series of indispensable revision/study guides created especially for pharmacy students. Each book focuses on what pharmacy students really need to know in order to pass exams, providing concise, bulleted information, key points, tips and an all-important self-assessment section which includes MCQs, case studies, sample essay questions and worked examples. The FASTtrack series provides the ultimate lecture notes and is a must-have for all pharmacy students wanting to study and test themselves for forthcoming exams. FASTtrack: Pharmaceutical Compounding and Dispensing focuses on what pharmacy students really need to know in order to pass exams, providing concise, bulleted information, key points, tips and an all-important self-assessment section which includes MCQs, case studies, sample essay questions and worked examples.Based on the successful textbook, Pharmaceutical Compounding and Dispensing, this FASTtrack book has been designed to assist the student compounder in understanding the key dosage forms encountered within extemporaneous dispensing. All the references to modern texts (for example, the BNF) have been updated for this new edition, as well as labelling to reflect changes since the publication of the first edition. Some worked examples have been changed owing to the availability of pharmaceutical ingredients. Readers are now given access to online videos demonstrating various dispensing procedures.
Der Drogenatlas bietet zu jeder Heilpflanze eine mikroskopische Farbtafel, ein makroskopisches Foto und eine botanisch exakte Beschreibung. Das Buch umfasst dabei Monographien der Drogen des Europaischen Arzneibuchs (Ph. Eur. 9.0), des Deutschen Arzneibuchs (DAB 2015) und des Deutschen Arzneimittel-Codex (DAC 2016). Die aussagekraftigen mikroskopischen Fotos der Farbtafeln charakterisieren die wichtigsten Drogenmerkmale im Zellverband. Besonders hilfreich sind UEbersichtsabbildungen in den Farbtafeln, die den allgemeinen Aufbau pflanzlicher Organe am Drogenbeispiel demonstrieren. Die makroskopischen Fotos zeigen charakteristische Drogenbestandteile. Der Textteil enthalt zusatzlich pragnante Angaben zu den Inhaltsstoffen und der Anwendung. Ein Glossar erklart alle wichtigen Fachbegriffe. Ausserdem finden Leser im Buch umfassende Informationen zur praktischen mikroskopischen Arbeit. Dieses Buch stellt eine sehr gute Basis fur die mikroskopischen Grundpraktika in der Pharmazeutischen Biologie dar. Der Farbatlas hilft Studierenden der Pharmazie und pharmazeutisch-technischen AssistentInnen in der Ausbildung effektiver zu praparieren, das selbst Mikroskopierte anhand der klaren Abbildungen zu verstehen und in Zeichnungen umzusetzen. Aber auch Apotheker und PTAs in der Offizin und Industrie und andere Naturwissenschaftler werden dieses Buch sehr zu schatzen wissen. Die nun mehr 3. Auflage wurde auf mehr als 180 Monographien erweitert. Die Texte wurden grundlich uberarbeitet und aktualisiert. Im Anhang wurde dem Praparieren und den histologischen Farbungen ein groesserer Stellenwert durch Farbbilder und eine ausfuhrliche Beschreibung eingeraumt. Im Bereich der Anwendungen wurden die neuesten HMPC-Monographien einbezogen. Die AutorinDr. Bettina Rahfeld, geb. 1963 in Karl-Marx-Stadt. 1981 bis 1986 Studium der Biologie an der Martin-Luther-Universitat Halle-Wittenberg (MLU). 1985 bis 1989 Forschungsstudium am Institut fur Genetik der MLU. Promotion 1989, Institut fur Genetik der MLU. 1989 bis 1992 wissenschaftliche Assistentin an der Klinik fur Innere Medizin der MLU. Seit 1992 wissenschaftliche Mitarbeiterin am Institut fur Pharmazie, Institutsbereich Pharmazeutische Biologie der MLU.
Pharmacists are on the frontlines of public health. Their public-facing roles uniquely position them to identify and address emerging disease challenges, discrepancies in health literacy, and barriers to treatment in the communities they serve. In today's interconnected world, the clients consulting a neighborhood pharmacist are just as likely to hail from across an ocean as they are from around the corner. Fittingly, Introduction to Public Health in Pharmacy, Second Edition takes an approach that is both global and local. Macro-level examinations of health care systems and funding mechanisms around the world and advice for culturally competent, client-centered communication regarding nutrition and proper self-administration of medications encapsulate pharmacists' dual roles as guardians of global public health and providers of personalized care. Written in accordance with the latest guidelines from the Center for the Advancement of Pharmacy Education, Introduction to Public Health in Pharmacy, Second Edition offers an accessible introduction for pharmacy students and a comprehensive refresher for pharmacists already in practice.
This book provides a comprehensive introduction to advanced drug delivery and targeting, covering their principles, current applications, and potential future developments. This edition has been updated to reflect significant trends and cutting-edge advances that have occurred since the first edition was published. All the original chapters have been retained, but the material therein has been updated. Eight new chapters have been added that deal with entirely new technologies and approaches. Features: Offers a comprehensive introduction to the fundamental concepts and underlying scientific principles of drug delivery and targeting Presents an in-depth analysis of the opportunities and obstacles afforded by the application of nanotechnologies for drug delivery and targeting Includes a revised and expanded section on the major epithelial routes of drug delivery currently under investigation Describes the most recent, emerging, and innovative technologies of drug delivery Provides real-life examples of the clinical translation of drug delivery technologies through the use of case studies Discusses the pertinent regulatory hurdles and safety issues of drug delivery and targeting systems-crucial considerations in order to achieve licensing approval for these new technologies
This unique text helps students and healthcare professionals master the fundamentals of pharmacokinetics and pharmacodynamics. Written by distinguished international experts, it provides readers with an introduction to the basic principles underlying the establishment and individualization of dosage regimens and their optimal use in drug therapy. Up-to-date examples featuring currently prescribed drugs illustrate how pharmacokinetics and pharmacodynamics relate to contemporary drug therapy. Study problems at the end of each chapter help students and professionals gain a firm grasp of the material covered within the text.
This book series gives a comprehensive overview of the adverse effects of botanical medicines. It provides introductory information on Botany, Chemistry, Pharmacology and Uses, followed by an Adverse Reaction Profile subdivided according to organ and function. The third contribution to the series gives important information about eighteen specific medicinal herbs and important plant constituents. The herbs and constituents have been selected for several reasons, such as a prominent place in phytotherapy, clinical expectations about therapeutic potential and recent concern about a serious adverse reaction. The World Health Organization Regional Office for Europe (Copenhagen) has supported the book in the form of an acknowledgement that has been prepared by this Office.
Die Dunnschichtchromatographie (DC) ist besonders in der pharmazeutischen Analytik und der Lebensmittelanalytik eine haufig durchgefuhrte Trenntechnik. Wahrend es eine umfangreiche Literatur zum qualitativen Nachweis chemischer Substanzen mittels DC gibt, liegt der Fokus in diesem Buch bei der quantitativen Analyse."
"Lively, fun to read and filled with gems of wisdom-- a treasure of information from a man who knows as much as anyone in the world about medicinal plants."
Lippincott's Photo Atlas of Medication Administration uses the nursing process format to provide step-by-step nursing skills with rationales. In addition to comprehensive photographs to illustrate steps, the Photo Atlas also contains documentation guidelines and samples, and Unexpected Situations, which explain how to respond to unanticipated outcomes. Topics include preparing medications as well as administering medications by various routes.
The treatment of cancer has undergone dramatic evolutions in the past two decades and the provision of holistic care by a multidisciplinary team of specialists is emerging as the cornerstone of recent improvements in outcome. Accompanying this multidisciplinary approach is the increasing complexity of therapeutic agents and modalities utilized. Drugs in Cancer Care is a succinct, practical and user-friendly guide to commonly used drugs and non-surgical therapeutic modalities in oncology. This detailed yet concise handbook contains over 90 monographs of cancer care providing the information needed to deliver chemotherapy with safety and precision, including information on mechanism of action, clinical pharmacology, side effect profile, tumour indications, combination treatment and how to respond to the hepato-renal impairment seen in many patients with advanced cancer. In an easy to use A-Z format this handbook will appeal to a variety of healthcare professional involved in the provision of cancer care and medicine information and will become an essential and well-thumbed item in every oncologist's toolkit.
Taking medication is a common occurrence for many people, whether it is to soothe an aching head, regulate blood sugars, or to treat life threatening conditions, such as HIV or cancer. In the UK alone, over 900 million prescriptions are dispensed every year. Overseeing all of this are pharmacists: experts in medicines and their use. The Integrated Foundations of Pharmacy series supports those who are at the beginning of their journey to become a pharmacist. The reader will begin to understand how a drug molecule is made; the process that turns it into a medicine; the role the pharmacist has when dispensing that medicine; and what happens in the body when it is taken. Most importantly, the series shows how each of these aspects are integrated, reflecting the most up-to-date teaching practices. Therapeutics and Human Physiology: how medicines work introduces the range of physiological processes occurring in the different body systems, and shows how they respond to drugs that are administered. Online Resource Centre The Online Resource Centre to accompany Therapeutics and Human Physiology: how medicines work features: For registered adopters of the book: - Figures from the book, available to download. For students: - Self-assessment questions to help the reader to check and reinforce understanding of the material introduced in each chapter.
Psychopharmaka werden in jungster Zeit vermehrt als Mittel einer moeglichen Freiheitsbeschrankung besonders in Einrichtungen der stationaren Altenpflege angesehen. Der Autor beleuchtet das Thema sowohl pharmazeutisch und medizinisch als auch rechtsphilosophisch, insbesondere aber aus dem moral-philosophischen und ethischen Blickwinkel.
From "pharma bros" to everday household budgets, just how did the pharmaceutical industry betray its own history-and how can it return to its tradition of care? It's an unfortunate and life-threatening fact: one in five Americans has skipped vital prescriptions simply because of the cost. These choices are being made even though we have reached a point in the conveyance of medical options where cancers can be cured and sight restored for those blinded by rare genetic disorders. How, in this time of such advancements, did we reach a point, where people cannot afford the very things that could save their lives? As the COVID-19 global pandemic has pointed out, we need the leadership of scientists, researchers, public health officials and lawmakers alike to guide us through not only in times of a global health crisis, but also during far more mundane times. For the first time in decades, people from all walks of life face the same need for medicine. It is time to discuss the tough questions about drug pricing in an open, honest and, hopefully, transparent manner. But first we must understand how we, as a society, got here. Medicines are arguably the most highly regulated-and cost-inflated-products in the United States. The discovery, development, manufacturing and distribution of medicines is carried out by an ever more complex and crowded set of industries, each playing a part in a larger "pharmaceutical enterprise" seeking to maximize profits. But this was not always the case. The Price of Health is the reveals the story of how the pharmaceutical enterprise took shape and led to the present crisis. The reputation of the pharmaceutical industry is suffering from self-inflicted wounds and its continued viability, indeed survival, is increasingly questioned. Yet the drug makers do not shoulder all the blame or responsibility for the current price crisis. Deeply researched, The Price of Health gives us hope as to how we can still right the ship, even amidst the roiling storm of a global pandemic. How have medicines have been made and distributed to consumers throughout the years? What sea of changes that have contributed to rising costs? Some individuals, actions, and systems will be familiar, others may surprise. Yet the combined implications of these actions for will be surprising and at times shocking to both industry professionals and average Americans alike. Like so much else in human history, the history of the pharmaceutical enterprise is populated mostly by well-intended and even noble individuals and organizations. Each contributed to the formation or maintenance of structures meant to improve the quality and quantity of life through the development and distribution of medicines. And yet systems originally created to do good have often been subverted in ways contrary to the motivations of their creators. Only by understanding this disconnect can we better tackle the underlying problems of the industry head on, preventing foreseeable, and thus avoidable, medical calamities to come.
Designed for primary care clinicians, this book is about patients who suffer with long term pain. Written in a distinct, friendly style, it analyses ideas about pain from the simple to the complex and provides up-to-date and relevant information written by doctors whose practice is either wholly or substantially related to people with pain. It provides examples of everyday patients to provide clinicians with the confidence to prescribe and treat patients with more difficult pain. In an attempt to 'demystify' some areas of pain medicine it also includes details of the science behind common conditions and their remedies in order to emphasise the psychological and social impacts of pain.
The Oxford Handbook of Dialysis is a comprehensive and practical guide to all aspects of dialysis, the management of patients with end stage kidney disease, and all its complications. The fourth edition has been completely updated, and covers all aspects of dialysis from haemodialysis techniques and haemodiafitration, to the medical, nursing and psychosocial aspects of managing patients with end stage kidney failure. Renal transplantation, plasma exchange, palliative care, and drug dosing are discussed, along with end of life care, and complications of chronic kdney disease. This handbook is packed with practical guidance and management, presented in a compact and easy to use format. The Oxford Handbook of Dialysis is aimed at all health care professionals dealing with dialysis patients from nephrologists to dieticians, as well as pharmacists, nurses, and surgeons. There are specific chapters on nursing patients on haemodialysis and peritoneal dialysis, and detailed nutrition and drug prescribing chapters. The fourth edition includes new sections on renal replacement therapies in acute kidney injury, home dialysis, new peritoneal dialysis fluids, new drugs including new epoietins and phosphate binders, updated sections on nocturnal dialysis, dialysis monitoring, encapsulating peritoneal sclerosis, and sleep disorders. Easy to read, practical, and focussed, this handbook should have a home in every renal unit, dialysis centre, renal ward, and be close to hand for every nephrologist, renal trainee, or renal nurse. |
You may like...
Mission Impossible 6: Fallout
Tom Cruise, Henry Cavill, …
Blu-ray disc
(1)R271 Discovery Miles 2 710
High Resolution Separation and Analysis…
John N. Abelson, Melvin I. Simon
Hardcover
R3,809
Discovery Miles 38 090
|